Pages that link to "Q38238094"
Jump to navigation
Jump to search
The following pages link to The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics (Q38238094):
Displaying 50 items.
- Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and Cancer (Q26740617) (← links)
- Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine (Q26796247) (← links)
- Sugar-coated sperm: Unraveling the functions of the mammalian sperm glycocalyx (Q27001029) (← links)
- Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe (Q27347532) (← links)
- Insights into the key roles of proteoglycans in breast cancer biology and translational medicine (Q28085548) (← links)
- Cancer metastases: challenges and opportunities (Q28088755) (← links)
- Mechanisms of heparanase inhibitors in cancer therapy (Q30244089) (← links)
- Human papillomavirus capsids preferentially bind and infect tumor cells (Q36470809) (← links)
- Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis (Q36498218) (← links)
- Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma (Q36524769) (← links)
- Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors (Q36572132) (← links)
- Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate (Q36906823) (← links)
- Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth (Q36917969) (← links)
- Tissue-specificity of heparan sulfate biosynthetic machinery in cancer. (Q37114695) (← links)
- Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage (Q37225598) (← links)
- Sulfatase 2 facilitates lymphangiogenesis in breast cancer by regulating VEGF-D. (Q37419274) (← links)
- Heparanase is required for activation and function of macrophages. (Q37473740) (← links)
- The prognostic significance of heparanase expression in metastatic melanoma (Q37688833) (← links)
- The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. (Q38290246) (← links)
- Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries (Q38528036) (← links)
- The glycocalyx and its significance in human medicine (Q38691530) (← links)
- NK cell heparanase controls tumor invasion and immune surveillance (Q38701256) (← links)
- The Heparanase Inhibitor PG545 Attenuates Colon Cancer Initiation and Growth, Associating with Increased p21 Expression (Q38718475) (← links)
- Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms (Q38749053) (← links)
- Heparan sulfate proteoglycans mediate renal carcinoma metastasis. (Q38750936) (← links)
- Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases (Q38801721) (← links)
- Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma (Q38815363) (← links)
- Proteoglycans as potential microenvironmental biomarkers for colon cancer. (Q38906085) (← links)
- Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy (Q38985052) (← links)
- Heparanase and cancer progression: New directions, new promises (Q41118533) (← links)
- Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis (Q41233173) (← links)
- BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. (Q41979268) (← links)
- Heparanase: From basic research to therapeutic applications in cancer and inflammation (Q42587945) (← links)
- High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature (Q45264401) (← links)
- Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation (Q47102962) (← links)
- Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells (Q47327922) (← links)
- Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression (Q47377873) (← links)
- Tailoring Natural Killer cell immunotherapy to the tumour microenvironment. (Q49956252) (← links)
- Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer. (Q55054468) (← links)
- Cancer Cell Glycocalyx and Its Significance in Cancer Progression (Q57168005) (← links)
- Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis (Q58573362) (← links)
- Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity (Q58585910) (← links)
- Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression (Q58705289) (← links)
- Leukocyte Heparanase: A Double-Edged Sword in Tumor Progression (Q64081265) (← links)
- Heparanase Promotes Tumor Growth and Liver Metastasis of Colorectal Cancer Cells by Activating the p38/MMP1 Axis (Q64084878) (← links)
- TRF2 positively regulates SULF2 expression increasing VEGF-A release and activity in tumor microenvironment (Q64230103) (← links)
- Mitochondrial superoxide dismutase 2 mediates γ-irradiation-induced cancer cell invasion (Q64238661) (← links)
- The Natural Cytotoxicity Receptors in Health and Disease (Q64248384) (← links)
- Interaction of poly(l-lysine)/polysaccharide complex nanoparticles with human vascular endothelial cells (Q66436083) (← links)
- Heparanase Loosens E-Cadherin-Mediated Cell-Cell Contact via Activation of Src (Q89622368) (← links)